Sorry, you need to enable JavaScript to visit this website.

This site is intended only for healthcare professionals resident in the United Kingdom

Prescribing information can be found at the bottom of the page

Ecalta® has more favourable pharmacokinetics than micafungin and caspofungin1-5

    •    Steady state is achieved more rapidly with Ecalta®1
    •    Longer half life (~24 hours)2-4
    •    Larger volume of distribution (30-50 L) than micafungin*2,4,5
    •    Rapid distribution half life (0.5-1 hour)2
 

Echinocandin half life in plasma1

Full preview Steady state plasma concentrations achieved

Adapted from Glöckner 2009

* Data not available for Caspofungin

References

    1.     Glöckner A, et al. Mycoses 2009;52(6):476–486.
    2.     Ecalta® Summary of Product Characteristics.
    3.     Cancidas (formerly Caspofungin MSD) Summary of Product Characteristics.
    4.     Micafungin Summary of Product Characteristics.
    5.     Raasch RH. Expert Rev Anti Infect Ther 2004;2(4):499–508.